Market Place
Sourcing Support
All News #Library
Biotech
AACR Data Support TKa Use And CDK Dose Optimization
18 Mar 2026 //
ACCESSWIRE
Biovica Announces Outcome of Rights Issue
05 Aug 2025 //
ACCESSWIRE
Biovica Launches DiviTum(R) TKa for Use in Early Breast Cancer
25 Jul 2025 //
ACCESSWIRE
Year-End Report 2024/2025
18 Jun 2025 //
ACCESSWIRE
Biovica resolves SEK 80m rights issue at SEK 0.63/share
11 Jun 2025 //
ACCESSWIRE
Notice of Extra General Meeting in Biovica International AB
11 Jun 2025 //
ACCESSWIRE
Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company
11 Jun 2025 //
ACCESSWIRE
Biovica Signs Major Service Agreement and First 4 MSEK Study
19 May 2025 //
ACCESSWIRE
Biovica Q3 Interim report Nov 2024 - Jan 2025
13 Mar 2025 //
ACCESSWIRE
Biovica signs new work order with US biotech for TKa testing
10 Mar 2025 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.